Modius's OpenData DCIM platform provides real-time insights into data center infrastructure, enabling capacity management, improved uptime and enhanced energy efficiency. With over 250 deployments ...

There was a turnaround in Equity in net earnings of Associates from a loss of US$0.4million in 1Q2025 to a profit of US$0.7million in 2Q2025. This resulted in a gain of US$0.6million from Investment ...

Biolog, a leading provider of microbial identification and phenotypic characterization tools and services, announced today that both its anaerobic media and anaerobic chambers have received CE marking ...

Osaka, Japan, July 29, 2025 - (JCN Newswire) - Osaka Prefecture has finalized the detailed program for the OSAKA JAPAN SDGs ...

The project is also the first grassland carbon project in China receiving both VCS certification and the Climate, Community ...

当前机器人行业步入"交付元年"，而首程控股正同时见证两条主线的高效兑现。宇树IPO即将开启退出窗口，加速进化则已在国际赛事中站上高点。两条路径背后，指向的是首程控股"系统布局+平台运营"模式的实际成效。值得关注的是，尽管已具备高分红（2024年派息近11亿港元，股息率达8%）与机器人产业深度布局，首程控股的估值仍在低位，市场对其"类债稳定+科技成长"的双重属性尚未充分定价。

透過產業基金，首程已布局銀河通用、松延動力、星海圖、墨現科技等關鍵企業，形成涵蓋感知、模型、本體、交互的「具身智能生態」。同時，公司搭建了銷售、租賃、渠道、開發者社群等支撐機制，並於自有園區、機場、停車場等場景落地應用。

On July 18, China’s securities regulator (CSRC) announced that Unitree has completed its IPO tutoring and is now preparing for official filing. As a global leader in the shipment of quadruped and ...

近年來，國泰君安國際自身通過系統性節能减排舉措持續降低營運碳足迹，爲連續實現「碳中和」提供核心支撑，舉措包括：大力推行辦公空間節能改造、深化數字化與無紙化轉型，以及實施嚴格的廢弃物管理（2024年有害廢弃物實現100%安全回收）。持之以恒的內部减排努 ...

第一階段結果顯示，SUL-238 是一種首創的口服粒線體標靶候選藥物，在健康老年志願者中安全性良好、耐受性良好，具備良好的藥物動力學特徵，並能高效穿透腦部。上述研究結果支持將 SUL-238 推進至治療阿茲海默症及其他神經退化性疾病的後續臨床開發階段 ...

ZUNVEYL was approved in July 2024 by the U.S. Food and Drug Administration (FDA) for the treatment of mild-to-moderate dementia of the Alzheimer’s type in adults. As a new generation of ...

Phase 1 results demonstrate that SUL-238, a first-in-class, orally administered, mitochondria-directed drug candidate, is ...